Background It is encountering the dilemma of lacking precise biomarkers to predict the response to neoadjuvant chemoimmunotherapy (NACI) and determine whether patients should use immune checkpoint inhibitors (ICIs) in early breast cancer (BC). We aimed to develop a gene signature to predict NACI response for BC patients and identify individuals suitable for adding ICIs. Patients and methods Two I-SPY2 cohorts and one West China Hospital cohort of patients treated with NACI were included. Machine learning algorithms were used to identify key genes. Principal component analysis was used to calculate the ImPredict (IP) score. The interaction effects between biomarkers and treatment regimens were examined based on the logistic regression analysis. The relationship between the IP score and immune microenvironment was investigated through immunohistochemistry (IHC) and multiplex IHC. Results The area under the curves of the IP score were 0.935, 0.865, and 0.841 in the discovery cohort, validation cohort 1, and in-house cohort. Marker-treatment interaction tests indicated that the benefits from immunotherapy significantly varied between patients with high and low IP scores (p for interaction <0.001), and patients with high IP scores were more suitable for immunotherapy addition. Conclusions Our IP model shows favorable performance in predicting NACI response and is an effective tool for identifying BC patients who will benefit from ICIs. It may help clinicians optimize treatment strategies and guide clinical decision-making.
Ferroptosis is a distinct form of regulated necrotic cell death driven by iron-dependent phospholipid peroxidation, characterized by flexible and context-dependent mechanisms rather than a single fixed linear pathway. This study elucidates the critical lipid peroxidation networks and antioxidant defense systems used in determining ferroptosis, specifically emphasizing how these mechanisms underpin the plasticity of this cell death mode and its correlation with therapeutic resistance. We examine the catastrophic propagation of ferroptosis, detailing the multi-layered amplification mechanisms—ranging from intracellular organelle crosstalk to intercellular trigger waves—that may facilitate massive tissue damage in degenerative diseases and ischemic injuries. Furthermore, the evolutionary conservation of ferroptosis-like phenomena across diverse species is summarized, underscoring its fundamental role in development and host–pathogen interactions. To conclude, we explore pivotal knowledge gaps that remain in our understanding of ferroptosis. By integrating these complex regulatory networks, this review provides a comprehensive framework for understanding ferroptosis as an adaptable, self-amplifying process, informing future efforts to modulate ferroptosis in disease contexts. Notably, this review focuses on the amplification, execution, and propagation phases of ferroptosis rather than on its initial triggering mechanisms, which remain an area of active investigation.